Pharmacotherapy for alcohol use disorder: current and emerging therapies
- PMID: 25747925
- PMCID: PMC4790835
- DOI: 10.1097/HRP.0000000000000079
Pharmacotherapy for alcohol use disorder: current and emerging therapies
Abstract
Alcohol use disorder is a heterogeneous illness with a complex biology that is controlled by many genes and gene-by-environment interactions. Several efficacious, evidence-based treatments currently exist for treating and managing alcohol use disorder, including a number of pharmacotherapies that target specific aspects of biology that initiate and maintain dangerous alcohol misuse. This article reviews the neurobiological and neurobehavioral foundation of alcohol use disorder, the mechanisms of action and evidence for the efficacy of currently approved medications for treatment, and the literature on other emerging pharmacotherapies.
Conflict of interest statement
References
-
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5. Arlington, VA: American Psychiatric Publishing; 2013.
-
- National Institute on Alcohol Abuse and Alcoholism. Tenth special report to the US Congress on alcohol and health. Washington, DC: US Department of Health and Human Services; 2000. http://pubs.niaaa.nih.gov/publications/10report/chap01.pdf.
-
- Bouchery EE, Harwood HJ, Sacks JJ, Simon CJ, Brewer RD. Economic costs of excessive alcohol consumption in the U.S. 2006. Am J Prev Med. 2011;41:516–24. - PubMed
-
- Swift RM. Drug therapy for alcohol dependence. N Engl J Med. 1999;340:1482–90. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical